| Primary |
| Atrial Fibrillation |
28.4% |
| Hypertension |
14.7% |
| Drug Use For Unknown Indication |
6.9% |
| Depression |
3.9% |
| Diabetes Mellitus |
3.9% |
| Gout |
3.9% |
| Hyperlipidaemia |
3.9% |
| Pain |
3.9% |
| Pancytopenia |
3.9% |
| Prophylaxis |
3.9% |
| Back Pain |
2.9% |
| Respiratory Tract Infection |
2.9% |
| Type 2 Diabetes Mellitus |
2.9% |
| Blood Pressure Abnormal |
2.0% |
| Bronchiectasis |
2.0% |
| Cardiac Failure |
2.0% |
| Deep Vein Thrombosis |
2.0% |
| Dyslipidaemia |
2.0% |
| Essential Hypertension |
2.0% |
| Ischaemic Cardiomyopathy |
2.0% |
|
| International Normalised Ratio Increased |
15.0% |
| Abdominal Wall Haematoma |
10.0% |
| Drug Interaction |
7.5% |
| Renal Failure Acute |
7.5% |
| Subdural Haematoma |
7.5% |
| Upper Gastrointestinal Haemorrhage |
7.5% |
| Cerebral Haemorrhage |
5.0% |
| International Normalised Ratio Fluctuation |
5.0% |
| Subarachnoid Haemorrhage |
5.0% |
| Vomiting |
5.0% |
| Abdominal Wall Haemorrhage |
2.5% |
| Coagulation Factor Xi Level Decreased |
2.5% |
| Dysarthria |
2.5% |
| Extradural Haematoma |
2.5% |
| Gastrointestinal Haemorrhage |
2.5% |
| Haematoma |
2.5% |
| Muscle Haemorrhage |
2.5% |
| Rectal Haemorrhage |
2.5% |
| Renal Failure |
2.5% |
| Renal Haematoma |
2.5% |
|
| Secondary |
| Drug Use For Unknown Indication |
20.7% |
| Atrial Fibrillation |
17.9% |
| Product Used For Unknown Indication |
12.9% |
| Hypertension |
10.5% |
| Atrial Flutter |
3.3% |
| Pain |
3.1% |
| Cardiac Failure |
3.0% |
| Hypertensive Heart Disease |
3.0% |
| Depression |
2.7% |
| Anticoagulant Therapy |
2.6% |
| Ill-defined Disorder |
2.5% |
| Prophylaxis |
2.5% |
| Type 2 Diabetes Mellitus |
2.4% |
| Diabetes Mellitus |
2.1% |
| Constipation |
2.0% |
| Osteoporosis |
1.9% |
| Arrhythmia |
1.8% |
| Essential Hypertension |
1.7% |
| Thrombosis Prophylaxis |
1.7% |
| Pulmonary Embolism |
1.6% |
|
| International Normalised Ratio Increased |
26.9% |
| Prothrombin Time Prolonged |
9.6% |
| Thrombocytopenia |
7.2% |
| Melaena |
5.3% |
| Drug Interaction |
4.8% |
| Vomiting |
4.3% |
| Haematoma |
3.8% |
| Rectal Haemorrhage |
3.8% |
| Renal Failure Acute |
3.8% |
| Renal Failure |
3.4% |
| Subdural Haematoma |
3.4% |
| Anaemia |
2.9% |
| Cerebral Haemorrhage |
2.9% |
| International Normalised Ratio Decreased |
2.9% |
| Overdose |
2.9% |
| Epistaxis |
2.4% |
| Gastrointestinal Haemorrhage |
2.4% |
| Muscle Haemorrhage |
2.4% |
| Retroperitoneal Haematoma |
2.4% |
| Total Lung Capacity Decreased |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
14.6% |
| Drug Use For Unknown Indication |
14.5% |
| Hypertension |
14.3% |
| Atrial Fibrillation |
12.1% |
| Osteoporosis |
7.4% |
| Prophylaxis |
5.6% |
| Pain |
4.1% |
| Rheumatoid Arthritis |
3.2% |
| Cardiac Failure |
2.8% |
| Multiple Myeloma |
2.8% |
| Diabetes Mellitus |
2.7% |
| Arrhythmia |
2.7% |
| Depression |
2.3% |
| Type 2 Diabetes Mellitus |
2.0% |
| Thrombosis Prophylaxis |
1.6% |
| Atrial Flutter |
1.5% |
| Coronary Artery Disease |
1.5% |
| Hypercholesterolaemia |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Essential Hypertension |
1.4% |
|
| Renal Failure Acute |
13.4% |
| Vomiting |
12.8% |
| Renal Failure |
6.8% |
| Syncope |
6.8% |
| Thrombocytopenia |
5.7% |
| Weight Decreased |
5.1% |
| Hyperkalaemia |
4.7% |
| Somnolence |
4.3% |
| Tremor |
4.3% |
| Cardiac Failure |
4.2% |
| Drug Interaction |
4.0% |
| Hyponatraemia |
3.8% |
| Atrial Fibrillation |
3.6% |
| Hypoglycaemia |
3.2% |
| Tachycardia |
3.2% |
| Hypotension |
3.0% |
| Sepsis |
3.0% |
| Pulmonary Embolism |
2.8% |
| Death |
2.6% |
| Fall |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
22.5% |
| Atrial Fibrillation |
22.2% |
| Drug Use For Unknown Indication |
12.9% |
| Atrial Flutter |
11.5% |
| Hypertension |
4.5% |
| Prophylaxis |
4.3% |
| Depression |
3.0% |
| Anticoagulant Therapy |
2.6% |
| Pain |
1.9% |
| Essential Hypertension |
1.7% |
| Myocardial Ischaemia |
1.7% |
| Dyslipidaemia |
1.6% |
| Unevaluable Event |
1.5% |
| Cardiac Valve Prosthesis User |
1.4% |
| Cardiac Failure |
1.3% |
| Hypercalcaemia |
1.3% |
| Hyperlipidaemia |
1.3% |
| Hypothyroidism |
1.1% |
| Cardiac Flutter |
1.0% |
| Diabetes Mellitus |
1.0% |
|
| International Normalised Ratio Increased |
23.8% |
| Drug Interaction |
22.3% |
| Prothrombin Time Prolonged |
7.8% |
| Petechiae |
6.2% |
| Upper Gastrointestinal Haemorrhage |
6.2% |
| Haemorrhage |
3.6% |
| International Normalised Ratio Decreased |
3.6% |
| Subdural Haematoma |
3.6% |
| Haematoma |
3.1% |
| Thrombocytopenia |
2.6% |
| Gastrointestinal Haemorrhage |
2.1% |
| Hypochromic Anaemia |
2.1% |
| Muscle Haemorrhage |
2.1% |
| Renal Failure Acute |
2.1% |
| Retroperitoneal Haematoma |
2.1% |
| Vaginal Haemorrhage |
2.1% |
| Gingival Bleeding |
1.6% |
| Anaemia |
1.0% |
| Cardiac Tamponade |
1.0% |
| Coagulopathy |
1.0% |
|
